Floatz logo

Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells

Parkinsonism

Indonesia UniversityCell therapyN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Parkinsonism cohort.

Asset / SponsorPhaseRating
Zoledronate
California Pacific Medical Center Research Institute
Phase 4BB
Meta-Iodobenzylguanidine
Mayo Clinic
Phase 4BB
IOFLUPANE
Mayo Clinic
Phase 4BB
Zonisamide
The Cooper Health System
Phase 4B
Varenicline Tartrate
Corporal Michael J. Crescenz VA Medical Center
Phase 4B
Droxidopa
The Cooper Health System
Phase 4B
ub-312
United Neuroscience Ltd.
Phase 1CC
Ramelteon
Northwestern University
N/AD

Same molecule, other indications

Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells is also rated in:

cerebral infarctionDormant
CCC
Indicative ·
50 / 100
View asset →
cirrhosis of liverDormant
CCC
Indicative ·
48 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →